# Epidemiological Characteristics of COVID-19 in Patients With MS or NMO

> **NCT04355611** · — · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 2465 (actual)

## Conditions studied

- Multiple Sclerosis
- NMO Spectrum Disorder
- COVID-19

## Interventions

- **OTHER:** Evaluation of the epidemiological characteristics of coronavirus infection (SARS-CoV-2)

## Key facts

- **NCT ID:** NCT04355611
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-17
- **Primary completion:** 2022-06-30
- **Final completion:** 2022-06-30
- **Target enrollment:** 2465 (ACTUAL)
- **Last updated:** 2024-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04355611

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04355611, "Epidemiological Characteristics of COVID-19 in Patients With MS or NMO". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04355611. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*